免責聲明: 本站彙整 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公開資料,僅供一般參考,不構成醫療建議、診斷、治療建議或投資建議。

FDA 510(k)

HemosIL ReadiPlasTin

K 號:K213426 · 2022-08-16

決定日期2022-08-16
產品代碼GJS
諮詢委員會HE 請提供完整的描述文本,以便我能夠進行翻譯。
決定相當於

器材摘要

HemosIL ReadiPlasTin is the device name listed in this FDA 510(k) record. The listed applicant is Instrumentation Laboratory CO. It received FDA 510(k) clearance on 2022-08-16 under 510(k) number K213426. The device is classified under product code GJS. It was reviewed by the HE advisory panel. FDA Decision: Substantially Equivalent.

常見問題

What is the HemosIL ReadiPlasTin?

HemosIL ReadiPlasTin is a medical device that received FDA 510(k) clearance on 2022-08-16. The listed applicant is Instrumentation Laboratory CO. The 510(k) number is K213426.

When did HemosIL ReadiPlasTin receive FDA 510(k) clearance?

HemosIL ReadiPlasTin received FDA 510(k) clearance on 2022-08-16, under 510(k) number K213426.

Who is the listed applicant for HemosIL ReadiPlasTin?

The FDA 510(k) record lists Instrumentation Laboratory CO as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for HemosIL ReadiPlasTin?

The FDA product code for HemosIL ReadiPlasTin is GJS.

相關臨床試驗

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

其他以 Instrumentation Laboratory CO 為申請人之記錄

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

查看所有 25 項裝置 →

相關器械(代碼:GJS)

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

官方來源

在 FDA 資料庫中查看 →

資料來源為 FDA Open API。如需最新且權威的資訊,請始終參閱官方記錄。

↑